Safinamide Metabolite B |
|
| Synonyms: (S,Z)-1-amino-N-(4-(3-fluorobenzyloxy)benzylidene)-1-oxopropan-2-amine oxide, Safinamide N-oxide | |
| Cat. No.: S00421 | CAS No.: N.A. |
| MDL.: | Formula: C17H17FN2O3 |
| F.W.316.33 | Purity: 99% |
| Storage: Refrigerator | |
|   | |
| Catalog Number: | S00421 | CAS No.: | N.A. | |
| MDL: | Formula: | C17H17FN2O3 | ||
| F.W.: | 316.33 | Purity: | 99% | |
| Package: | Unit: | mg | ||
| Appearance: | M.P.: | |||
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | DCM, Ethyl acetate | Stability: | ||
| Storage: | Refrigerator | Category: | Reference Standard | |
| Reference: | N.A. | |||
| Application: | (S,Z)-N-(1-amino-1-oxopropan-2-yl)-1-(4-((3-fluorobenzyl)oxy)phenyl)methanimine oxide is a metabolite of Safinamide. Safinamide is a potent and selective MAO-B inhibitor, and is used as an add-on treatment to treat Parkinson’s disease. | |||
| Category: | Aromatics, Chiral Reagents, Pharmaceuticals, Intermediates & Fine Chemicals | |||








